Related Experiment Videos
A case of acute myocardial infarction due to primary coronary dissection
1Department of Internal Medicine, Chikuhou Rousai Hospital, Fukuoka, Japan.
Insights
Primary coronary dissection causing acute myocardial infarction in a 46-year-old woman resolved over 4 months. Angiography showed a false lumen initially, which later disappeared, with improved true lumen flow.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Acute myocardial infarction (AMI) can arise from spontaneous coronary artery dissection (SCAD).
- SCAD is a rare cause of AMI, particularly in younger women without traditional cardiovascular risk factors.
- Understanding the natural history and angiographic evolution of SCAD-related AMI is crucial for patient management.
Abstract:
A case of acute myocardial infarction associated with primary coronary dissection was followed up angiographically. A 46-year-old woman complained of chest oppression. Electrocardiogram on admission showed ST-segment elevation in V1-5. Urgent coronary angiography was performed under a diagnosis of acute anterior myocardial infarction, and showed a significant stenosis with multiple filling defects in segments 7-8 (99% with severe delay) in the left anterior descending artery. There was no organic lesion in the right coronary artery. Intracoronary thrombolytic therapy was unsuccessful, and thereafter she was treated with aspirin, warfarin and isosorbide dinitrate. Coronary angiography performed 1 month later revealed a long dissection with double lumens in segments 7-8. The septal branches emerged from the smaller lumen. Two months later, the 2 lumens were almost equal in size. These findings indicated that coronary dissection produced a false lumen with an entry in segment 7 and a reentry in segment 8, and that the false lumen was responsible for the greater flow. Four months later, the flow in the true lumen had improved remarkably while that in the false lumen had almost disappeared. She remained in stable condition during the follow-up period of 4 months.